Trial Profile
Treatment received and other factors of patients with metastatic colorectal cancer who initiated treatment with regorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2015
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 02 Jun 2015 New trial record